Risperidone
Q&A with W. David Lohr: Antipsychotics, polypharmacy among autistic preschoolers
Hundreds of preschool-aged children in Kentucky began taking antipsychotic medicines in 2012, according to an analysis of Medicaid records. Lohr discusses what it will it take to get them behavioral therapies instead.
Q&A with W. David Lohr: Antipsychotics, polypharmacy among autistic preschoolers
Prenatal exposure to antipsychotic medication does not increase odds of autism, ADHD
Children born to mothers who take antipsychotic drugs during pregnancy are not more likely to have autism or attention deficit hyperactivity disorder, or to be born preterm or underweight.
Prenatal exposure to antipsychotic medication does not increase odds of autism, ADHD
Q&A with Eric Hollander: Cannabis treatments for autism
As cannabis prohibition slowly lifts in the United States, scientists and families in the autism community are increasingly turning to the drug and its constituent compounds to ease autism-related difficulties, including seizures and irritability.
Q&A with Eric Hollander: Cannabis treatments for autism
Medical ‘home’ programs offer coordinated care for autistic people
A Utah program provides comprehensive care for autistic people across the lifespan and engages families in the decision-making.
Medical ‘home’ programs offer coordinated care for autistic people
Clinicians should consider off-label treatments for autism
Clinicians need a more consistent and evidence-based approach to prescribing antipsychotics to children and adolescents with autism.
Clinicians should consider off-label treatments for autism
Psychotropic drugs frequently prescribed for autistic people
About one in three autistic people in the United Kingdom is prescribed drugs designed to alter brain function.
Psychotropic drugs frequently prescribed for autistic people
Revelando los secretos del síndrome X frágil en Colombia
Una remota ciudad colombiana es el hogar del grupo más grande de personas con síndrome de X frágil. Los científicos están aprendiendo de ellos y tratando de ayudar.
Revelando los secretos del síndrome X frágil en Colombia
Unlocking the secrets of fragile X in Colombia
A remote Colombian town is home to the world's largest cluster of people with fragile X syndrome. Scientists are learning from them — and trying to help.
Unlocking the secrets of fragile X in Colombia
Rebooting Becky’s brain
An electrical brain implant all but erased the obsessions that had consumed Becky Audette, years after her autism diagnosis. Could similar implants help other people with severe autism?
Drug dangers; allergy risk; science #MeToo and more
A prospective study shows that antipsychotics mess up metabolism, autism is tied to a doubled risk for food allergies, and a report reveals pervasive sexual harassment in science.
Drug dangers; allergy risk; science #MeToo and more
Explore more from The Transmitter
Rat neurons thrive in a mouse brain world, testing ‘nature versus nurture’
Neurons from the two rodents can wire up together to form functional circuits—all while maintaining some species-specific properties, two new studies show.
Rat neurons thrive in a mouse brain world, testing ‘nature versus nurture’
Neurons from the two rodents can wire up together to form functional circuits—all while maintaining some species-specific properties, two new studies show.
It’s past time to stop using the Reading the Mind in the Eyes Test
The widely used measure of “theory of mind” needs to be re-examined, along with the long-standing claim that autism is linked to a lack of this ability.
It’s past time to stop using the Reading the Mind in the Eyes Test
The widely used measure of “theory of mind” needs to be re-examined, along with the long-standing claim that autism is linked to a lack of this ability.
Robots boost data consistency in rodent studies reliant on mechanical, optogenetic stimulation
Two new devices take experimenter variation out of the equation, the lead investigators say.
Robots boost data consistency in rodent studies reliant on mechanical, optogenetic stimulation
Two new devices take experimenter variation out of the equation, the lead investigators say.